Methadone's Effect on Cardiac Repolarization: Safety in the PICU

Area of Science:

• Pediatric critical care medicine
• Clinical pharmacology
• Cardiology

Background:

• Opioids are common in the Pediatric Intensive Care Unit (PICU).
• Methadone effectively manages opioid withdrawal but has a FDA Boxed Warning for QT interval prolongation and arrhythmias.
• Pediatric-specific data on methadone's electrophysiologic effects, particularly corrected QT interval changes, is limited.

Purpose of the Study:

• To evaluate the safety of methadone in critically ill children.
• To determine if methadone significantly alters the corrected QT interval in this population.
• To hypothesize that methadone does not cause a significant change in corrected QT interval from baseline.

Main Methods:

• Retrospective cohort study including 51 pediatric patients (age ≤18 years) receiving methadone in the PICU.
• Data collected from electronic health records and telemetry waveforms.
• Corrected QT intervals were analyzed at baseline, 12 hours, 96 hours, and PICU discharge.

Main Results:

• No significant difference in corrected QT intervals was observed at 12 hours, 96 hours, or PICU discharge compared to baseline (p > 0.05).
• Median changes in corrected QT interval were small (≤5 ms) at various time points.
• Patients with structural heart disease were more likely to experience an increase in corrected QT interval ≥40 ms.

Conclusions:

• Methadone can be safely administered to critically ill children without causing significant QT interval prolongation.
• Patients with underlying structural heart disease may require closer cardiac monitoring when using methadone.
• Further research may explore specific monitoring strategies for high-risk pediatric patients.